Changes of Nerve Growth Factor in Amniotic Fluid and Correlation with Ventriculomegaly

doi:10.1016/S1001-9294(11)60029-1

Abstract

Abstract: Objective To detect the change of nerve growth factor (NGF) level in human amniotic fluid during gestation, and to explore the relationship between this change and fetal ventriculomegaly (VM).
Methods The studied subjects (collected from 2004 to 2007) were divided into four groups, including the second-trimester pregnancy group (n=113), third-trimester pregnancy group (n=110), fetal cerebral VM group (n=12), and healthy control group (n=12) which matched with the VM group in gestational weeks. The amniotic fluid specimens were obtained during amniocentesis or cesarean section. The NGF levels in amniotic fluid were detected with enzyme-linked immunosorbent assay.
Results A significantly negative correlation was found between gestational age and the NGF level in amniotic fluid (r=−0.6149, P<0.0001). The NGF level in patients with fetal VM was significantly lower than that in healthy controls (33.95±29.24 pg/mL vs. 64.73±16.21 pg/mL, P=0.024).
Conclusion NGF levels in amniotic fluid may be a sensitive marker for fetal VM.

Key words: nerve growth factor, amniotic fluid, fetal ventriculomegaly

Xiao-yan Xia, Xing-hua Huang, Yi-xin Xia*, and Wei-hua Zhang . Changes of Nerve Growth Factor in Amniotic Fluid and Correlation with Ventriculomegaly[J].Chinese Medical Sciences Journal, 2011, 26(2): 109-112.

References 13

1.	Tyler WJ, Perrett SP, Pozzo-Miller LD. The role of neurotrophinsin neurotransmitter release. Neuroscientist 2002; 8:524-31.
2.	Huang EJ, Reichardt LF. Neurotrophins: roles in neuronaldevelopment and function. Annu Rev Neurosci 2001; 24: 677-736.
3.	Mashayekhi F, Salehi Z. Infusion of anti-nerve growth factorinto the cisternum magnum of chick embryo leads to decrease cell production inthe cerebral cortical germinal epithelium. Eur J Neurol 2007; 14:181-6.
4.	Gaglioti P, Oberto M, Todros T. Thesignificance of fetal ventriculomegaly: etiology, short- and long-term outcomes.Prenat Diagn 2009; 29:381-8.
5.	Garel C, Luton D, Oury JF, et al. Ventricular dilatations.Childs Nerv Syst2003; 19:517-23.
6.	Leitner Y, Stolar O, Rotstein M, etal. The neurocognitive outcome of mild isolated fetal ventriculomegaly verifiedby prenatal magnetic resonance imaging. Am J Obstet Gynecol 2009; 201:215.e1-6.
7.	Gaglioti P, Danelon D, Bontempo S, et al. Fetal cerebralventriculomegaly: outcome in 176 cases. Ultrasound Obstet Gynecol 2005;25:372-7.
8.	Martinez-Zamora MA, Borrell A, Borobio V, et al. Falsepositives in the prenatal ultrasound screening of fetal structural anomalies.Prenat Diagn 2007; 27:18-22.
9.	Xing J, Lu J, Li J. Contribution of nerve growth factor toaugmented TRPV1 responses of muscle sensory neurons by femoral arteryocclusion. Am J Physiol Heart Circ Physiol 2009; 296:H1380-7.
10	Cunningham FG, Leveno KJ, Bloom SL, et al. Fetal growth anddevelopment. In: Cunningham FG, Leveno KJ, Bloom SL, et al, editors. Williams obstetrics.22nd ed. New York:McGraw-Hill; 2005. p. 91-120.
11	Mashayekhi F, Azari M, Moghadam LM, et al. Changes incerebrospinal fluid nerve growth factor levels during chick embryonicdevelopment. J Clin Neurosci 2009;16:1334-7.
12	Marx CE, Vance BJ, Jarskog LF, etal. Nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3levels in human amniotic fluid. Am J Obstet Gynecol 1999; 181:1225-30.
13	Cunningham FG, Leveno KJ, Bloon SL, et al. Prenatal diagnosisand fetal therapy. In: Cunningham FG, Leveno KJ, Bloom SL, et al, editors.Williams obstetrics. 22nd ed. NewYork: McGraw-Hill; 2005. p.313-39.




	*Correspondingauthor Tel: 86-10-57976668, E-mail: xinyibj@ 126.com
	△Supported by Fund for ScientificResearch of Overseas Chinese Students by Beijing Personnel Bureau.

Early edition

Current issue

Archive

Specialties & Topics

Author center

Reviewer center